ResearcherShandong University of Traditional Chinese MedicineNo recent work listed

Weiguang Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3730-9154; OpenAlex author ID A5100393232. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 5

Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: 1 paper

Papers 2

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Milad Ashrafizadeh · 1 shared paper, 2023 · strength 0.15
- Paper Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. DOI 10.1016/j.drup.2023.101005 ↗
Xianbin Zhang · 1 shared paper, 2023 · strength 0.15
- Paper Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. DOI 10.1016/j.drup.2023.101005 ↗
Peng Gong · 1 shared paper, 2023 · strength 0.15
- Paper Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. DOI 10.1016/j.drup.2023.101005 ↗
Wei Zhang · 1 shared paper, 2023 · strength 0.15
- Paper Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. DOI 10.1016/j.drup.2023.101005 ↗
Jiahui Yuan · 1 shared paper, 2023 · strength 0.15
- Paper Cell membrane-camouflaged bufalin targets NOD2 and overcomes multidrug resistance in pancreatic cancer. DOI 10.1016/j.drup.2023.101005 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.